Paclitaxel Modulates the Proliferation and Differentiation of THP-1 Cells Exposed to Inactivated SARS-CoV-2 Virus

Paclitaxel Modulates the Proliferation and Differentiation of THP-1 Cells Exposed to Inactivated SARS-CoV-2 Virus

Introduction: Cancer patients were considered a high-risk group for COVID-19. Studies indicate that certain types of cancer, as breast cancer, may exhibit distinct immunological responses. Evidence suggests that paclitaxel (PTX), a chemotherapeutic agent widely used in the treatment of breast cance...

Full description

Saved in:
Bibliographic Details
Main Authors: Everaldo Hertz, Bárbara Osmarin Turra, Nathália Cardoso de Afonso Bonotto, Fernanda dos Santos Trombini, João Arthur Bittencourt Zimmermann, Cibele Ferreira Teixeira, Verônica Farina Azzolin, Ivo Emilio da Cruz Jung, Ivana Beatrice Mânica da Cruz, Fernanda Barbisan
Format: Article
Language:English
Published: Instituto Nacional de Câncer (INCA) 2025-05-01
Series:Revista Brasileira de Cancerologia
Subjects:
Breast Cancer/drug therapy
Paclitaxel
COVID-19
Cytokine Release Syndrome
Cytotoxicity, Immunologic/drug effects
Online Access:https://rbc.inca.gov.br/index.php/revista/article/view/5107
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items